Smoking at time of diagnosis and breast cancer-specific survival: New findings and systematic review with meta-analysis

Breast Cancer Research

Volumn 16, Issue 2, 2014, Pages

  Bérubé, Sylvie ^a,b   Lemieux, Julie ^a,b,c   Moore, Lynne ^a,c   Maunsell, Elizabeth ^a,b,c   Brisson, Jacques ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b Université Laval   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CORRELATIONAL STUDY; DIABETES MELLITUS; DISTANT METASTASIS; FAMILY HISTORY; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PARITY; PARTIAL MASTECTOMY; POSTMENOPAUSE; SMOKING; SYSTEMATIC REVIEW; TUMOR VOLUME; BREAST NEOPLASMS; CANADA; CAUSE OF DEATH; EPIDEMIOLOGY; FEMALE; META ANALYSIS; MORTALITY; MULTIVARIATE ANALYSIS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; TRENDS;

BREAST NEOPLASMS; CANADA; CAUSE OF DEATH; FEMALE; HUMANS; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84901465884     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3646     Document Type: Article

References (51)

1. Carmack CL, Basen-Engquist K, Gritz ER. Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. Cancer Epidemiol Biomarkers Prev 2011, 20:2068-2077. 10.1158/1055-9965.EPI-11-0627, 21980014.
2. Wei EK, Wolin KY, Colditz GA. Time course of risk factors in cancer etiology and progression. J Clin Oncol 2010, 28:4052-4057. 10.1200/JCO.2009.26.9324, 20644083.
3. Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E. Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 2009, 114:13-22. 10.1007/s10549-008-9990-8, 18389367.
4. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013, 132:401-410. 10.1002/ijc.27617, 22539012.
5. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat 2012, 136:521-533. 10.1007/s10549-012-2276-1, 3507472, 23053660.
6. Hellmann SS, Thygesen LC, Tolstrup JS, Gronbaek M. Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study. Eur J Cancer Prev 2010, 19:366-373. 10.1097/CEJ.0b013e32833b4828, 20502344.
7. Rezaianzadeh A, Peacock J, Reidpath D, Talei A, Hosseini SV, Mehrabani D. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer 2009, 9:168. 10.1186/1471-2407-9-168, 2699348, 19497131.
8. Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008, 123:2188-2194. 10.1002/ijc.23747, 18711698.
9. Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007, 120:2672-2677. 10.1002/ijc.22575, 17278091.
10. Aksoy S, Harputluoglu H, Guler N, Altundag K, Hayran M, Tekuzman G, Ozisik Y. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen. Breast J 2007, 13:431-432. 10.1111/j.1524-4741.2007.00459.x, 17593056.
11. Fentiman IS, Allen DS, Hamed H. Smoking and prognosis in women with breast cancer. Int J Clin Pract 2005, 59:1051-1054. 10.1111/j.1742-1241.2005.00581.x, 16115181.
12. Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, Malina J, Matson S. Survival of women with breast cancer in relation to smoking. Eur J Surg 2000, 166:852-858. 10.1080/110241500447227, 11097150.
13. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 1998, 82:1310-1318. 10.1002/(SICI)1097-0142(19980401)82:7<1310::AID-CNCR14>3.0.CO;2-9, 9529023.
14. Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 1997, 21:497-509.
15. Tominaga K, Andow J, Koyama Y, Numao S, Kurokawa E, Ojima M, Nagai M. Family environment, hobbies and habits as psychosocial predictors of survival for surgically treated patients with breast cancer. Jpn J Clin Oncol 1998, 28:36-41. 10.1093/jjco/28.1.36, 9491140.
16. Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Britton JA, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Ann Epidemiol 2007, 17:385-393. 10.1016/j.annepidem.2006.11.004, 17395485.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
18. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004, 57:1288-1294. 10.1016/j.jclinepi.2004.03.012, 15617955.
19. Berube S, Provencher L, Robert J, Jacob S, Hebert-Croteau N, Lemieux J, Duchesne T, Brisson J. Quantitative exploration of possible reasons for the recent improvement in breast cancer survival. Breast Cancer Res Treat 2007, 106:419-431. 10.1007/s10549-007-9503-1, 17268811.
20. Montgomery DC. Experiments with a single factor: the analysis of variance. Design and Analysis of Experiments 2008, 87-89. Hoboken, NJ: John Wiley & Sons, 7.
21. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 1993, 80:557-572.
22. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 2002, 11:953-971.
23. Li C. Breast Cancer Epidemiology, Fred Hutchinson Cancer Research Center 2010, Springler: University of Washington, Seattle.
24. Collishaw NE, Boyd NF, Cantor KP, Hammond SK, Johnson KC, Millar J, Miller AB, Miller M, Palmer JR, Salmon AG, Turcotte F. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. OTRU Special Report Series 2009, Toronto: Ontario Tobacco Research Unit, OTRU Special Report Series, Available at: http://otru.org/canadian-expert-panel-tobacco-smoke-breast-cancer-risk-full-report.
25. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2011, 34:892-897. 10.2337/dc10-2087, 3064047, 21355099.
26. Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Molecular prognostic factors for breast cancer metastasis and survival. Semin Radiat Oncol 2002, 12:319-328. 10.1053/srao.2002.35251, 12382190.
27. Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP. Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol 2009, 169:1463-1470. 10.1093/aje/kwp077, 2733768, 19403844.
28. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364:829-841.
29. Santini D, Vincenzi B, Adamo V, Addeo R, Fusco V, Russo A, Montemurro F, Roato I, Redana S, Lanzetta G, Satolli MA, Berruti A, Leoni V, Galluzzo S, Antimi M, Ferraro G, Rossi M, Del Prete S, Valerio MR, Marra M, Caraglia M, Tonini G. Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. Oncol Rep 2011, 25:1545-1548.
30. Little RJ, Rubin DB. Statistical Analysis with Missing Data 2002, New York: John Wiley, 2.
31. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 338:b2393. 10.1136/bmj.b2393, 2714692, 19564179.
32. Ali AM, Dawson SJ, Blows FM, Provenzano E, Ellis IO, Baglietto L, Huntsman D, Caldas C, Pharoah PD. Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer. Br J Cancer 2011, 104:693-699. 10.1038/sj.bjc.6606078, 3049587, 21266980.
33. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
34. The Cochrane Collaboration http://ims.cochrane.org/revman, Accessed June 2011, The Cochrane Collaboration.
35. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods 2006, 11:193-206.
36. Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD. Risk factors for the incidence of breast cancer: do they affect survival from the disease?. J Clin Oncol 2008, 26:3310-3316. 10.1200/JCO.2006.10.3168, 18612147.
37. Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991, 49:526-530. 10.1002/ijc.2910490409, 1917153.
38. Vatten LJ, Foss OP, Kvinnsland S. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer 1991, 27:641-646. 10.1016/0277-5379(91)90234-5, 1828977.
39. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005, 23:5814-5830. 10.1200/JCO.2005.01.230, 1550285, 16043830.
40. Singh S, Pillai S, Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol 2011, 2011:456743. 3085312, 21541211.
41. Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst 2013, 105:515-525. 10.1093/jnci/djt023, 23449445.
42. Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005, 23:8884-8893. 10.1200/JCO.2005.02.2343, 16314649.
43. Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol 2012, 30:3697-3704. 10.1200/JCO.2012.42.0638, 23008316.
44. Maunsell E, Drolet M, Brisson J, Robert J, Deschenes L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol 2002, 20:1017-1025. 10.1200/JCO.20.4.1017, 11844825.
45. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 2010, 102:1584-1598. 10.1093/jnci/djq366, 2957430, 20937991.
46. Mook S, Vant Veer LJ, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, Visser O, Schmidt MK. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst 2011, 103:585-597. 10.1093/jnci/djr043, 21350218.
47. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA 2011, 305:2548-2555. 10.1001/jama.2011.879, 3562349, 21693743.
48. Health Canada: Health concerns Tobacco. Canadian Tobacco Use Monitoring Survey (CTUMS) [http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2012/ann-histo-eng.php], Health Canada: Health concerns.
49. Canadian Cancer Society/National Cancer Institute of Canada Canadian Cancer Statistics 2007, Toronto, Canadian Cancer Society/National Cancer Institute of Canada.
50. Ellison LF, Wilkins K. Mise à jour sur la survie au cancer. Statistique Canada. Rapports sur la santé, vol 21, no 3 2010, Canada S. Ottawa (Ontario).
51. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138. 10.1016/S0140-6736(10)62231-3, 3018568, 21183212.